福瑞股份收盘上涨2.94%，滚动市盈率119.72倍，总市值118.76亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Furuya Co., which has a closing price of 44.82 yuan, a PE ratio of 119.72, and a total market value of 11.876 billion yuan [1][2] - Furuya Co. ranks 107th in the medical device industry based on PE ratio, with the industry average at 54.89 and the median at 37.06 [1][2] - The company experienced a net inflow of 15.51 million yuan in principal funds on July 31, with a total inflow of 27.94 million yuan over the past five days [1] Group 2 - Furuya Co. specializes in the production and sales of drugs in the liver disease field, development and sales of diagnostic equipment, and related medical services, with its main product being the compound turtle shell soft liver tablets [1] - In the latest quarterly report for Q1 2025, the company achieved an operating income of 330 million yuan, a year-on-year increase of 2.35%, while net profit was 28.64 million yuan, a year-on-year decrease of 32.97%, with a gross profit margin of 76.76% [1]